April 27, 2022
CADTH is expanding its Scientific Advice program to include applications for advice on real-world evidence (RWE) generation plans after protocols for pivotal trials have been finalized. This is an opportunity for pharmaceutical companies to enhance their engagement with CADTH regarding RWE.
April 5, 2022
A message from David Agnew, Chair of the CADTH Board of Directors, and Suzanne McGurn, President and CEO of CADTH
We’re pleased to share Ahead of the Curve: Shaping Future-Ready Heath Systems, CADTH’s new 3-year strategic plan.
Our new strategic plan situates CADTH at the heart of a new, ever-…
April 5, 2022
CADTH is seeking nominations for its expert and advisory committees. We are currently accepting applications from individuals with significant expertise in the Canadian health care system who are interested in helping support health care decision-makers in making informed choices about health…
April 4, 2022
Proposals aim to help improve the accessibility and appropriate use of publicly funded drugs
CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process for drug class reviews.
Non-Sponsored Reimbursement Reviews
Currently, a sponsor (…
March 17, 2022
New Horizon Scan report offers insights on health technology trends that have the potential to harness large volumes of data, improve clinical workflows, and bring accessible health care closer to home
OTTAWA, March 17, 2022 — Point-of-care testing. Artificial intelligence. Voice technology.…